Large CRE Deals Come Roaring Back: What Q3 2025 Means for Today’s Professionals

City skyline sunrise

After several quarters of hesitation, the U.S. commercial real estate market saw a major pulse of confidence in Q3 2025. According to fresh data from Altus Group, large single‑asset deals valued at $10 million or more surged back into the spotlight, hitting $76 billion for the quarter — the strongest performance since 2022.

For professionals across real estate, finance, and investment sectors, this shift isn’t just a statistic. It’s a directional signal: liquidity is returning, high‑value buyers are stepping back in, and the upper tier of the market is showing long‑awaited signs of normalization.

The Return of the Big Deal

Altus Group’s Q3 2025 Investment & Transactions Report reveals a notable trend reversal. For the first time in several quarters, both quarterly and annual deal counts increased. But what truly stands out is the composition — large, single‑asset transactions made a powerful comeback.

Q3 2025 recorded 1,826 single‑asset deals above $10M — the highest since Q3 2022.

This accounted for nearly 68% of all single‑asset dollars traded, a level not seen since mid‑2022. Even outside the record‑breaking volatility of the post‑pandemic period, this quarter delivered the strongest growth rate for major deals in more than a decade.

A Market Rebound — But Not a Full Return to Peak Conditions

Despite the strong resurgence in activity, overall transaction volume still trails the highs of 2021 and 2022. The main cause? Deal size. The median large‑deal value landed at $19.6 million, roughly 9% below the late 2021 peak of $21.4 million.

Every major sector remains below its historic high:

Industrial: 1.7% below peak
Multifamily: 8.2% below peak
Office: 23.8% below peak
Retail: 6.1% below peak

Office continues to be the long‑term laggard, while industrial remains closest to full recovery. Multifamily, meanwhile, is showing renewed momentum with a 14.2% rise from post‑pandemic lows.

Pricing Trends Hint at Stabilization

The median price per square foot across property types rose 0.6% both quarterly and annually — a subtle but encouraging sign of stabilization. Office properties, however, continue their downward drift, losing 3% QoQ and 4.4% YoY.

Investors appear increasingly comfortable re‑entering the market, even if valuations remain below peak highs — suggesting improved price discovery and growing confidence in long‑term underwriting.

Why This Matters for Today’s Professionals

Commercial real estate often acts as a barometer for broader economic risk appetite. The return of large‑scale deals signals that institutional players believe conditions are returning to equilibrium. For real estate agents, mortgage professionals, and investors, this means new opportunities are emerging.

For those looking to upskill or transition into CRE roles, now is the time to enhance your professional profile. Schools like Cameron Academy provide flexible, career‑focused licensing and continuing education designed to keep professionals competitive during shifting market cycles.

A Step Toward Market Normalization

The key question now: will this momentum continue? As borrowing costs settle and underwriting clarity improves, Q4 and early 2026 could bring even greater liquidity — or a cautious pause.

For now, Q3 stands as the clearest sign in years that capital is flowing back into the big‑deal segment — and that investors are once again ready to make meaningful, future‑focused moves.

Read the full Altus Group analysis

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The Remote Work Revolution: Redefining Real Estate

Imagine a morning where the commute is just a few steps from your bedroom to your home office. This is the reality for many in today's post-pandemic world, where remote work has become a staple of the modern workforce.

By |December 2, 2024|Categories: Article, Real Estate, Remote Work|Tags: , |0 Comments

CRISPR: The Future of Gene Editing and Its Clinical Implications

CRISPR technology has become the frontrunner in genome editing, surpassing earlier methods like zinc finger nucleases and transcription activator-like effector nucleases. The recent FDA approval of the CRISPR-Cas9 drug, exa-cel, marks a significant milestone particularly for treating sickle cell disease and transfusion-dependent beta thalassemia.

By |December 1, 2024|Categories: Article, Biotechnology, Medicine|Tags: , |0 Comments

AI Revolution in Oncology: Transformative Potential or Overhyped?

In recent years, artificial intelligence has emerged as a revolutionary tool in the field of oncology. AI's integration into healthcare transcends buzzwords, transforming cancer diagnosis, treatment personalization, and drug discovery.

AI in Radiology: A Double-Edged Sword

The rapid advancements in artificial intelligence (AI) are transforming the landscape of radiology, promising to enhance diagnostic accuracy and support personalized medicine. However, as this technology becomes more integral to medical imaging, it brings with it a host of ethical and societal considerations that cannot be ignored.

Humanity at the Crossroads: Ethical Implications of AI in Medicine

AI's promise in healthcare is undeniable, with its ability to uncover hidden disease patterns and predict illnesses. However, the reliance on historical data can exacerbate existing biases, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic and racial groups.

The Future of Telemedicine: Challenges and Opportunities Beyond the Pandemic

Telemedicine stands out as a transformative force, offering a lifeline to patients and providers alike. As we move beyond the pandemic, the challenge is to integrate this technology without escalating costs or overshadowing the indispensable role of in-person consultations.

By |November 30, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments